EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Senolytic Treatment Alleviates Corneal Allograft Rejection Through Upregulation of Angiotensin-Converting Enzyme 2 (ACE2)

Hao Chi, Li Ma, Fanxing Zeng, Xiaolei Wang, Peng Peng, Xiaofei Bai, Ting Zhang, Wenhui Yin, Yaoyao Yu, Lingling Yang, Qingjun Zhou, Chao Wei and 1 more

Investigative Ophthalmology & Visual Science · 2025

DOI: 10.1167/iovs.66.2.15 ↗

At a glance

Journal article in Investigative Ophthalmology & Visual Science, 2025. Written by Hao Chi and 12 co-authors. Institution: State Key Laboratory Cultivation Base, Shandong Key Laboratory of Eye Diseases, Eye Institute of Shandong First Medical University, Qingdao, China. Major MEDLINE topics: Graft Rejection, Corneal Transplantation, Aniline Compounds, Sulfonamides. Cited 4 times so far (Crossref); 45 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Purpose

Allograft rejection remains a major cause of failure in high-risk corneal transplants, but the underlying mechanisms are not fully understood. This study aimed to investigate the contribution of transplantation stress-induced cellular senescence to corneal allograft rejection and to elucidate the associated molecular mechanisms.

Methods

Age-matched murine corneal transplantation models were established. Cellular senescence was evaluated using senescence-associated β-galactosidase (SA-β-Gal) staining, western blot, and immunofluorescence staining. The role of cellular senescence in corneal allograft rejection was analyzed using p16 knockout mice and adoptive transfer experiments. Senolytic treatment with ABT-263 was administered intraperitoneally to evaluate its effects on corneal allograft rejection. RNA sequencing and pharmacological approaches were employed to identify the underlying mechanisms.

Results

Surgical injury induced a senescence-like phenotype in both donor corneas and recipient corneal beds, characterized by an increased accumulation of SA-β-Gal-positive cells in the corneal endothelium and stroma and elevated expression of senescence markers p16 and p21. Using genetic and adoptive transfer models, transplantation stress-induced senescence was shown to exacerbate corneal allograft rejection. Importantly, clearance of senescent cells by ABT-263 significantly suppressed ocular alloresponses and immune rejection. Mechanistically, RNA sequencing and loss-of-function experiments demonstrated that the anti-rejection effects of senolytic treatment were closely dependent on angiotensin-converting enzyme 2 (ACE2).

Conclusions

These findings highlight transplantation stress-induced senescence as a pivotal pathogenic factor in corneal allograft rejection. Senolytic therapy emerges as a potential novel strategy to mitigate transplant rejection and improve corneal allograft survival.

Subjects

MeSH terms (MEDLINE)

Graft RejectionCorneal TransplantationAniline CompoundsSulfonamidesPeptidyl-Dipeptidase AAnimalsMiceMice, Inbred C57BLDisease Models, AnimalCellular SenescenceMice, KnockoutUp-RegulationAllograftsBlotting, WesternMice, Inbred BALB CTransplantation, HomologousGraft SurvivalMale

Substances

Aniline CompoundsSulfonamidesnavitoclaxPeptidyl-Dipeptidase A

Authors and institutions

  • State Key Laboratory Cultivation Base, Shandong Key Laboratory of Eye Diseases, Eye Institute of Shandong First Medical University, Qingdao, China.
  • Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, China.
  • School of Ophthalmology, Shandong First Medical University, Jinan, China.
  • Eye Hospital of Shandong First Medical University (Shandong Eye Hospital), Eye Institute of Shandong First Medical University, Jinan, China.
  • Eye Institute of Shandong First Medical University, Qingdao Eye Hospital of Shandong First Medical University, Qingdao, China.
  • https://orcid.org/0000-0003-1581-8377.

Cite

APA

Chi, H., Ma, L., Zeng, F., Wang, X., Peng, P., Bai, X., Zhang, T., Yin, W., Yu, Y., Yang, L., Zhou, Q., Wei, C., & Shi, W. (2025). Senolytic Treatment Alleviates Corneal Allograft Rejection Through Upregulation of Angiotensin-Converting Enzyme 2 (ACE2). Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.66.2.15

Vancouver

Chi H, Ma L, Zeng F, Wang X, Peng P, Bai X, et al. Senolytic Treatment Alleviates Corneal Allograft Rejection Through Upregulation of Angiotensin-Converting Enzyme 2 (ACE2). Investigative Ophthalmology & Visual Science. 2025. doi:10.1167/iovs.66.2.15

BibTeX
@article{Chi2025,
  author = {Chi, Hao and Ma, Li and Zeng, Fanxing and Wang, Xiaolei and Peng, Peng and Bai, Xiaofei and Zhang, Ting and Yin, Wenhui and Yu, Yaoyao and Yang, Lingling and Zhou, Qingjun and Wei, Chao and Shi, Weiyun},
  title = {Senolytic Treatment Alleviates Corneal Allograft Rejection Through Upregulation of Angiotensin-Converting Enzyme 2 (ACE2)},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2025},
  doi = {10.1167/iovs.66.2.15}
}
Start for free →